In this episode of Lung Cancer Considered, host Dr. Narjust Duma and Dr. Ibiayo Dagogo discuss BRAF mutated non-small cell lung cancer and some unique characteristics of patients with this mutation.
About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers. To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.
In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests Dr. Misako Nagasaka and Dr. Antonio Passaro discuss management of a Stage IV non-small cell lung cancer in this Virtual Tumor Board case study.
In this special musical edition of Lung Cancer Considered, Host Stephen Liu talks with physician-researcher and musician Dr. Thomas John from Melbourne, Australia. We think you’ll want to tune in and listen to the end as Dr. John, performing as Mayhemtom, shares his new single called ‘Reach Out’ from the album he is currently producing. The single is now available at: https://linktr.ee/mayhemtom Review: https://beat.com.au/mayhemtom-funnels-existential-drama-into-dreamy-indie-rock-on-his-debut-s...
In this special Italian-language edition of Lung Cancer Considered, host Dr. Alfredo Addeo examines lung cancer in Italy with Dr. Marina Garissino and Dr. Silvia Novello. The researchers discuss their thoughts on navigating a career as women oncologists in Italy and compare their perceptions about the differences in lung cancer screening and research between Italy and other countries.
In this edition of Lung Cancer Considered, host Narjust Duma and Dr. Fumiko Chino discuss a challenge to thoracic oncology which is financial toxicity associated with cancer care. The two women dive into the complexity of health insurance and the multifactorial situations that are associated with the care a patient receives. Dr. Chino also reveals her personal experience with financial toxicity and a cancer diagnosis of a family member.
The American Society of Clinical Oncology meeting just concluded and Lung Cancer Considered has a summary of the meeting, with a unique lung cancer focus. Tune in as host Stephen Liu and guests Dr. Alfredo Addeo and Dr. Heather Wakelee discuss key findings from ASCO 2021.
In this edition of Lung Cancer Considered, host Dr. Narjust Duma discusses the use of neoadjuvant immunotherapy, through a multidisciplinary lens, with guests Dr. Leah Backhus and Dr. Patrick Forde.
In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process. The interview also covers how new drug approvals are handled in other countries
In this episode of Lung Cancer Considered, guests Dr. Kristin A. Higgins and Dr. Antonio Calles discuss the case of a 42-year-old woman who presents to the emergency room with right shoulder pain and a dry cough that has worsened over the previous two months. A CT scan reveals she has a four-centimeter mass in her right lobe. Her PDL-1 is 1-2 percent. She has a limited history of smoking but no co-morbidities but she has lost 10 pounds since she was first seen in the emergency room.
This new episode of Lung Cancer Considered features a discussion of the seminal trial KEYNOTE 001 and how it impacted research and clinical care for patients with lung cancer. This podcast is noteworthy because, in addition to including researcher Dr. Eddie Garon, it also features the unique perspective from Cary Parton, a patient who participated in this trial.
This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undruggable, but results presented at WCLC 2020 from the CodeBreak 100 trial provide hope that new therapies will be more readily available.
The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board in mesothelioma, involving a case with a 68-year-old male, with 30 pack years smoking history who presents to the ER due to a worsening shortness of breath at rest and with exertion, unresectable mesothelioma with chest wall invasion and pleural effusion thickening with enlarged mediastinal lymph nodes and right chest wall invasion. Thoracentesis revealed a serosanguineous fluid (removed 1.1 l) with impro...
In this episode of Lung Cancer Considered, Dr. Sai-Hong Ignatius Ou shares his career growth and experience participating and leading breakthrough clinical trials on therapies to treat ALK positive patients with lung cancer. Dr. Ou discusses a pivotal moment at the beginning of his career when he visited the Pfizer campus in California to learn about their effort to develop a phase 1 trial examining MET amplifications and MET mutations. The visit helped spur him to become more involved in lung c...
This edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC: Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy cohorts CheckMate 9LA -- randomized 719 patients with EGFR/ALK wild type NSCLC to standard chemotherap...
The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board case involving squamous cell lung cancer. Our guests are Dr. Enriqueta Felip, who is a professor of medicine and section in chief, Medical Oncology and Department Director of Thoracic Oncology at the Vall d’Hebron University Hospital in Barcelona. Joining Dr. Felip is Dr. Paul Paik, an associate attending physician and clinical director, of the Thoracic Oncology Service Department of Medicine Memorial Slo...
This special episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and co-host Paul Bunn. Dr. Liu and Dr. Bunn are joined by, Dr. Tal Zaks, the chief medical officer at Moderna, and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the University of Colorado Cancer Center, former president of IASLC and ASCO. Dr. Moore serves as the director of Science and Research for the GO2 Foundation for Lung Cancer. Together, they...
The latest episode of Lung Cancer Considered features a conversation between host, Dr. Stephen Liu and Dr. Myung-Ju Ahn, professor in the Department of Hematology-Oncology at the Samsung Medical Center, Sungkyunkwan University School of Medicine in South Korea. Together they discuss Dr. Ahn's career and her work in ROS1 lung cancer.
The latest episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and Dr. Alex Drilon, chief, early drug development at Memorial Sloan Kettering Cancer Center. Together they discuss Dr. Drilon's career and his work on RET fusions in lung cancer.
The latest episode of Lung Cancer Considered features a conversation between host Dr. Narjust Duma and Dr. Balazs Halmos, professor of oncology and chief, thoracic/head and neck oncology at Montefiore Medical Center/Albert Einstein College of Medicine in New York. Together they discuss Dr. Halmos' career and his work on EGFR mutant non-small cell lung cancer.
Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma are joined by Dr. Ross Soo, a senior consultant in the Department of Hematology-Oncology at the National University of Cancer Institute Singapore to discuss highlights from the IASLC 2020 WCLC Singapore meeting. Dr. Soo, along with Dr. Yi-Long Wu and Dr. Daniel Tan, served as co-chair of the meeting. Together Dr. Liu, Dr. Duma and Dr. Soo discuss key science, highlights, benefits and challenges of the virtual meeting.
Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma share highlights, tips and tricks for navigating IASLC's World Conference on Lung Cancer Singapore this year. Listen to this podcast as you prepare for the world’s leading lung cancer event (held virtually January 28 – 31). Register for IASLC's WCLC at //wclc2020.iaslc.org/registration.
The latest episode of Lung Cancer Considered discusses women in thoracic oncology and the upcoming IASLC Women in Thoracic Oncology Event. Register now for this event. This episode features a conversation between host, Dr. Narjust Duma, and Dr. Heather Wakelee and Dr. Clarissa Mathias. Dr. Wakelee is a thoracic medical oncologist, Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology at Stanford University Medical Center. She is also the president-elect o...
The latest episode of Lung Cancer Considered introduces its new hosts, Dr. Stephen Liu and Dr. Narjust Duma. Dr. Liu is an associate professor at the Lombardi Cancer Center at Georgetown University School of Medicine. Dr. Duma is an assistant professor of medicine and a thoracic oncologist at the University of Wisconsin. Get to know both Dr. Liu and Dr. Duma a little more and hear what their goals are in 2021 for Lung Cancer Considered.
The latest episode of Lung Cancer Considered discusses biological and molecular staging as a dimension beyond sized-based staging. This episode features a conversation between host Dr. Jack West and Dr. Daniel Boffa, professor and division chief of thoracic surgery at Yale University.
The latest episode of “Lung Cancer Considered” discusses the practice patterns and clinical trials in India and how COVID-19 has impacted the field in India. This episode features a conversation between host Dr. Jack West and Dr. Vanita Noronha, professor of medical oncology at Tata Memorial Hospital, Mumbai, India.
The latest episode of Lung Cancer Considered brings you part two of our conversation on lung cancer stigma during Lung Cancer Awareness Month. This episode features a discussion with Jill Feldman, patient advocate; Terri Conneran, a three-time lung cancer survivor and advocate and director and founder of KRAS Kickers and the director of LiveLung International Relations; Jamie L. Studts, a professor in the division of medical oncology, department of medicine at the University of Colorado School o...
In the latest episode of Lung Cancer Considered, we kick off Lung Cancer Awareness Month focusing on stigma within the lung cancer community and what we can all do to understand and overcome it. This episode features a conversation between Jill Feldman, lung cancer patient advocate and co-founder of EGRF Resisters; Terri Conneran, a three-time lung cancer survivor and advocate and director and founder of KRAS Kickers and the director of LiveLung International Relations; Jamie L. Studts, a profes...
The latest episode of Lung Cancer Considered focuses on the data and clinical outcomes for patients who may go off immunotherapy after two years. This episode features a conversation between host Dr. Jack West and Dr. Matt Hellman, associate attending at Memorial Sloan Kettering Cancer Center.
In the latest episode of Lung Cancer Considered, we're going back to October 2019, pre-COVID, when Dr. Jack West interviewed Dr. Tony Mok about highlights and new research from the 2019 IASLC World Conference on Lung Cancer. We’re feeling nostalgic about being able to meet in person and heartened by how far we’ve come since our last time together.
